An observational study in ICU Patients, sponsored by University of Luebeck. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-18.
Sponsored by University of Luebeck · Observational
The purpose of the current study is to analyze the effects of ICU-care on changes in microbiome and the influence of intestinal microbiome changes on short-term and long-term morbidity and mortality of ICU patients.
University of Luebeck is the lead sponsor of 74 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients who receive treatment on ICU.
Exclusion Criteria:
Descriptive Analysis
Modification of the microbiome
The modification of the microbiome using ribosomal 16 S DNA sequencing and clustering for Operational Taxonomic Units (OTU) and calculated Shannon Index
Time frame: Day 0
ICU intensive care unit stay
Duration
Time frame: Day 0
Hospital stay
Duration
Time frame: Month 12
Hospital stay
Duration
Time frame: Month 6
Survival
To discharge
Time frame: Month 6
Survival
To discharge
Time frame: Month 12
This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Luebeck